Early safety of the Amplatzer Cardiac Plug™ for left atrial appendage occlusion

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 3920-3925

  Meerkin, David ^a   Butnaru, Adi ^a   Dratva, Dmitry ^a   Bertrand, Olivier F ^b,c,d,e   Tzivoni, Dan ^a,f  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e Quebec Foundation for Health Research   (Canada)

^f HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Atrial fibrillation; Device occlusion; Left atrial appendage; Stroke; Thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN;

AGED; AMPLATZER VASCULAR PLUG; ANTICOAGULANT THERAPY; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEVICE SAFETY; DRUG CONTRAINDICATION; EQUIPMENT DESIGN; FEMALE; FLUOROSCOPY; HEART ATRIUM APPENDAGE; HEART TAMPONADE; HIGH RISK PATIENT; HUMAN; LEFT ATRIAL APPENDAGE; LOADING DRUG DOSE; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PRIORITY JOURNAL; SCORING SYSTEM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT RESPONSE; ATRIAL FIBRILLATION; ECHOGRAPHY; HEART CATHETERIZATION; MIDDLE AGED; SEPTAL OCCLUDER; SURGERY; TIME; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CARDIAC CATHETERIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; SEPTAL OCCLUDER DEVICE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84886306209     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.06.062     Document Type: Article

References (15)

1. R.G. Hart, L.A. Pearce, and M.I. Aguilar Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 2007 857 867
2. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, and A.J. Camm Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
3. V. Fuster, L.E. Rydén, and D.S. Cannom ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society J Am Coll Cardiol 57 2011 e101 e198
4. S.J. Connolly, M.D. Ezekowitz, and S. Yusuf Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
5. M.R. Patel, K.W. Mahaffey, and J. Garg Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
6. C.B. Granger, J.H. Alexander, and J.J. McMurray Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
7. T.J. Bungard, W.A. Ghali, K.K. Teo, F.A. McAlister, and R.T. Tsuyuki Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 160 2000 41 46
8. R. Nieuwlaat, A. Capucci, and A.J. Camm Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on atrial fibrillation Eur Heart J 26 2005 2422 2434
9. J.L. Blackshear, and J.A. Odell Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation Ann Thorac Surg 61 1996 755 759
10. Y.L. Bayard, H. Omran, and P. Neuzil PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study EuroIntervention 6 2010 220 226
11. J.W. Park, B. Leithäuser, U. Gerk, M. Vrsansky, and F. Jung Percutaneous left atrial appendage transcatheter occlusion (PLAATO) for stroke prevention in atrial fibrillation: 2-year outcomes J Invasive Cardiol 21 2009 446 450
12. S.H. Ostermayer, M. Reisman, and P.H. Kramer Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials J Am Coll Cardiol 46 2005 9 14
13. D.R. Holmes, V.Y. Reddy, and Z.G. Turi Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial Lancet 374 2009 534 542
14. J.W. Park, A. Bethencourt, and H. Sievert Left atrial appendage closure with Amplatzer Cardiac Plug in atrial fibrillation: initial European experience Catheter Cardiovasc Interv 77 2011 700 706
15. V.Y. Reddy, D. Holmes, S.K. Doshi, P. Neuzil, and S. Kar Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry Circulation 123 2011 417 424